首页> 美国卫生研究院文献>other >Cell-Free Systems Based on CHO Cell Lysates: Optimization Strategies Synthesis of Difficult-to-Express Proteins and Future Perspectives
【2h】

Cell-Free Systems Based on CHO Cell Lysates: Optimization Strategies Synthesis of Difficult-to-Express Proteins and Future Perspectives

机译:基于CHO细胞裂解物的无细胞系统:优化策略难于表达的蛋白质合成和未来展望

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nowadays, biotechnological processes play a pivotal role in target protein production. In this context, Chinese Hamster Ovary (CHO) cells are one of the most prominent cell lines for the expression of recombinant proteins and revealed as a safe host for nearly 40 years. Nevertheless, the major bottleneck of common in vivo protein expression platforms becomes obvious when looking at the production of so called “difficult-to-express” proteins. This class of proteins comprises in particular several ion channels and multipass membrane proteins as well as cytotoxic proteins. To enhance the production of “difficult-to-express” proteins, alternative technologies were developed, mainly based on translationally active cell lysates. These so called “cell-free” protein synthesis systems enable an efficient production of different classes of proteins. Eukaryotic cell-free systems harboring endogenous microsomal structures for the synthesis of functional membrane proteins and posttranslationally modified proteins are of particular interest for future applications. Therefore, we present current developments in cell-free protein synthesis based on translationally active CHO cell extracts, underlining the high potential of this platform. We present novel results highlighting the optimization of protein yields, the synthesis of various “difficult-to-express” proteins and the cotranslational incorporation of non-standard amino acids, which was exemplarily demonstrated by residue specific labeling of the glycoprotein Erythropoietin and the multimeric membrane protein KCSA.
机译:如今,生物技术过程在靶蛋白生产中起着关键作用。在这种情况下,中国仓鼠卵巢(CHO)细胞是表达重组蛋白的最重要细胞系之一,并且已被揭示为近40年的安全宿主。然而,当观察所谓的“难于表达”的蛋白质的生产时,常见的体内蛋白质表达平台的主要瓶颈变得显而易见。这类蛋白质尤其包括几个离子通道和多通道膜蛋白质以及细胞毒性蛋白质。为了提高“难于表达”蛋白质的产量,主要基于翻译活性细胞裂解物开发了替代技术。这些所谓的“无细胞”蛋白质合成系统能够有效生产不同种类的蛋白质。带有内源性微粒体结构以合成功能性膜蛋白和翻译后修饰的蛋白的真核无细胞系统对未来的应用特别感兴趣。因此,我们介绍了基于翻译活性CHO细胞提取物的无细胞蛋白质合成的最新进展,突显了该平台的巨大潜力。我们提出了新颖的结果,突出了蛋白质产量的优化,各种“难于表达”的蛋白质的合成以及非标准氨基酸的共翻译结合,这可以通过糖蛋白促红细胞生成素和多聚体膜的残基特异性标记得到证明。蛋白质KCSA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号